Theravance Biopharma (TBPH) Gross Profit (QoQ) (2013 - 2018)
Theravance Biopharma (TBPH) Gross Profit (QoQ) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 24.50% |
| Sep 30, 2018 | -44.92% |
| Jun 30, 2018 | 193.98% |
| Mar 31, 2018 | 238.28% |
| Dec 31, 2017 | -32.67% |
| Sep 30, 2017 | 53.38% |
| Jun 30, 2017 | -14.95% |
| Mar 31, 2017 | -44.52% |
| Dec 31, 2016 | -75.75% |
| Sep 30, 2016 | 30.50% |
| Jun 30, 2016 | -18.55% |
| Mar 31, 2016 | 2,447.98% |
| Dec 31, 2015 | -93.16% |
| Sep 30, 2015 | 52.62% |
| Jun 30, 2015 | -66.90% |
| Mar 31, 2015 | 1,219.62% |
| Dec 31, 2014 | -129.98% |
| Sep 30, 2014 | 121.41% |
| Jun 30, 2014 | 256.01% |
| Mar 31, 2014 | 332.57% |